Drawing for HAEMOVAC

USPTO serial 71429265

HAEMOVAC

Reviewed by CopyMark Law Group

Reg. 0379042Status 710
Filing date
Status date
Registration date
Jun 25, 1940
Examiner
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with HAEMOVAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
044BLOOD TRANSFUSION SETS INCLUDING SEALED CONTAINERS HAVING A PARTIAL VACUUM AND CONTAINING A SOLUTION OF SODIUM CITRATE 21/2 PERCENT IN PHYSIOLOGICAL SOLUTION OF SODIUM CHLORIDE, NEEDLES, VALVES, CONNECTIONS, AND TUBINGSECTION 8 - CANCELLEDJan 10, 1939

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 13, 2009C8.TCANCELLED SEC. 8 (10-YR)
Jan 16, 2009CFITCASE FILE IN TICRS
Jan 8, 1985CANTCANCELLATION TERMINATED NO. 999999
Dec 7, 1984CANDCANCELLATION DENIED NO. 999999
Oct 25, 1984C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 5, 1984PETCCANCELLATION INSTITUTED NO. 999999
Jun 25, 1980REN2REGISTERED AND RENEWED (SECOND RENEWAL - 20 YRS)

Frequently asked questions

Related guidance